Basis: Latest reported fiscal quarter. Source: stored company filings and market data; unavailable inputs remain N/A.
Is the current ratio high or low?
The current ratio of 11.94 is 26% below its 5-year average of 16.11, near the low end of its 5-year range (7.96–31.37).
As of the fiscal period ended Tuesday, June 30, 2026. 9.59% above its 12-month average of 10.90.
Reported quarterly current ratio; no daily interpolation. Q2 FY2026 (2026-06-30): 11.94.
CURRENT RATIO
11.94
CURRENT RATIO AVG TTM
10.90
CURRENT RATIO AVG 3Y
14.29
CURRENT RATIO AVG 5Y
16.11
CURRENT RATIO AVG 10Y
16.88
CURRENT RATIO AVG 15Y
N/A
CURRENT RATIO AVG 20Y
N/A
CURRENT VS TTM AVG
+9.59%
CURRENT VS 3Y AVG
-16.46%
CURRENT VS 5Y AVG
-25.90%
CURRENT VS 10Y AVG
-29.24%
CURRENT VS 15Y AVG
N/A
CURRENT VS 20Y AVG
N/A
SECTOR MEDIAN · HEALTHCARE
3.75
median of 874 covered companies
CURRENT VS SECTOR MEDIAN
+218.41%
vs the sector median at left
Market Cap
$2.19B
Current Ratio
4.05
TTM Avg
7.06
3Y Avg
7.46
5Y Avg
6.71
Market Cap
$2.11B
Current Ratio
18.83
TTM Avg
6.22
3Y Avg
3.45
5Y Avg
3.57
Market Cap
$2.11B
Current Ratio
1.69
TTM Avg
1.73
3Y Avg
1.64
5Y Avg
1.89
Market Cap
$2.23B
Current Ratio
11.85
TTM Avg
5.21
3Y Avg
5.21
5Y Avg
5.21
Market Cap
$2.08B
Current Ratio
10.92
TTM Avg
19.66
3Y Avg
12.98
5Y Avg
14.20
Market Cap
$2.07B
Current Ratio
11.82
TTM Avg
14.70
3Y Avg
15.08
5Y Avg
16.52
| NAME | MARKET CAP | CURRENT RATIO | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| Pharvaris N.V. (PHVS) | $2.16B | 11.94 | 10.90 | 14.29 | 16.11 |
| Maravai LifeSciences Holdings, Inc. (MRVI)vs › | $2.19B | 4.05 | 7.06 | 7.46 | 6.71 |
| GeneDx Holdings Corp. (WGS)vs › | $2.13B | 3.30 | 3.04 | 2.66 | 2.96 |
| SELLAS Life Sciences Group, Inc. (SLS)vs › | $2.11B | 18.83 | 6.22 | 3.45 | 3.57 |
| Addus HomeCare Corporation (ADUS)vs › | $2.11B | 1.69 | 1.73 | 1.64 | 1.89 |
| Alamar Biosciences, Inc. (ALMR)vs › | $2.23B | 11.85 | 5.21 | 5.21 | 5.21 |
| Vera Therapeutics, Inc. (VERA)vs › | $2.08B | 10.92 | 19.66 | 12.98 | 14.20 |
| Alvotech (ALVO)vs › | $2.07B | 1.65 | 2.12 | 1.59 | 1.52 |
| Celldex Therapeutics, Inc. (CLDX)vs › | $2.07B | 11.82 | 14.70 | 15.08 | 16.52 |
| Viridian Therapeutics, Inc. (VRDN)vs › | $2.06B | 16.95 | 14.04 | 14.77 | 14.32 |
Current Ratio
11.94
Quick Ratio
11.94
Current Ratio = Current Assets / Current Liabilities
The current ratio measures short-term liquidity — a company's ability to cover current liabilities with current assets. Above 1.0 indicates positive working capital.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | CURRENT RATIO |
|---|---|
| 2026-06-30 | 11.94 |
| 2026-03-31 | 11.24 |
| 2025-12-31 | 10.11 |
| 2025-09-30 | 12.86 |
| 2025-06-30 | 8.33 |
| 2025-03-31 | 11.10 |
| 2024-12-31 | 12.60 |
| 2024-09-30 | 19.08 |
| 2024-06-30 | 18.45 |
| 2024-03-31 | 20.53 |
| 2023-12-31 | 27.25 |
| 2023-09-30 | 10.46 |
| 2023-06-30 | 11.89 |
| 2023-03-31 | 7.96 |
| 2022-12-31 | 9.16 |
| 2022-09-30 | 11.43 |
| 2022-06-30 | 12.85 |
| 2022-03-31 | 19.84 |
| 2021-12-31 | 30.28 |
| 2021-09-30 | 29.71 |
| 2021-06-30 | 31.37 |
| 2021-04-30 | 28.87 |
| 2020-12-31 | 19.00 |
| 2020-09-30 | 9.86 |
| 2020-06-30 | 19.00 |
| 2020-03-31 | 0.00 |
| 2019-12-31 | 10.70 |
| 2019-09-30 | 10.70 |
| 2019-06-30 | 10.70 |
| 2019-03-31 | 10.70 |
| 2018-12-31 | 11.29 |
| 2018-09-30 | 11.29 |
| 2018-06-30 | 11.29 |
| 2018-03-31 | 11.29 |
| 2017-12-31 | 34.55 |
| 2017-09-30 | 34.55 |
| 2017-06-30 | 34.55 |
| 2017-03-31 | 34.55 |
